References
- Wiener M, Guo Y, Patel G, Fries B. Lactic acidosis after treatment with linezolid. Infection. 2007; 35: 278–281.
- Apodaca AA, Rakita RM. Linezolid-induced lactic acidosis. N Engl J Med. 2003; 348: 86–87.
- Kopterides P, Papadomichelakis E, Armaganidis A. Line-zolid use associated with lactic acidosis. Scand J Infect Dis. 2005; 37: 153–154.
- Narita M, Tsuji BT, Yu VL. Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy. 2007; 27: 1189–1197.
- Palenzuela L, Hahn NM, Nelson RP, Jr., et al. Does line-zolid cause lactic acidosis by inhibiting mitochondrial protein syn-thesis? Clin Infect Dis. 2005; 40: e113–e116.
- Carson J, Cerda J, Chae J, Hirano M, Maggiore P. Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism. Pharmacotherapy. 2007; 27: 771–774.
- De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis. 2006; 42: 1111–1117.
- Garrabou G, Soriano A, Lopez S, et al. Reversible inhibi-tion of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother. 2007; 51: 962–967.
- McKee EE, Ferguson M, Bentley AT, Marks TA. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother. 2006; 50: 2042–2049.
- Soriano A, Miro O, Mensa J. Mitochondrial toxicity asso-ciated with linezolid. N Engl J Med. 2005; 353: 2305–2306.
- Fuser R, Torresan S, Carniato A, Giobbia M, Rossi C, Inojosa WO, Vaglia A. Early Linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis. Scotton Infec-tion. 2008 Aug; 36 (4): 387-8.